SEC Comment Letter for Vertex, Inc. (VERX) (CIK 0001806837) (VERX) — Apr 24, 2020
Vertex, Inc. (VERX) (CIK 0001806837)
Date: April 24, 2020 · CIK: 0001806837 · Accession: 0000000000-20-003539
AI Filing Summary & Sentiment
Show Raw Text
April 24, 2020
Bryan Rowland
General Counsel
Vertex, Inc.
2301 Renaissance Blvd.
King of Prussia, PA 19406
Re:Vertex, Inc.
Draft Registration Statement on Form S-1
Submitted March 30, 2020
File No. 377-03104
Dear Mr. Rowland:
We have reviewed your draft registration statement and have the following comments. In
some of our comments, we may ask you to provide us with information so we may better
understand your disclosure.
Please respond to this letter by providing the requested information and either submitting
an amended draft registration statement or publicly filing your registration statement on
EDGAR. If you do not believe our comments apply to your facts and circumstances or do not
believe an amendment is appropriate, please tell us why in your response.
After reviewing the information you provide in response to these comments and your
amended draft registration statement or filed registration statement, we may have additional
comments.
Draft Registration Statement submitted on March 30, 2020
Summary Consolidated Financial and Operating Information
Non-GAAP Financial Data (unaudited), page 12
1.Please revise to ensure that your presentations of non-GAAP financial data throughout
your filing are not more prominent than the comparable GAAP measures. In this regard,
also present the comparable GAAP measures for Adjusted EBITDA margin and free cash
flow margin. In addition, revise to include all three major categories of the statements of
cash flows with your presentation of free cash flow. Refer to Item 10(e)(1)(i)(A) of
Regulation S-K and Questions 102.06 and 102.10 of the Compliance and Disclosure
Interpretations of Non-GAAP Financial Measures.
FirstName LastNameBryan Rowland
Comapany NameVertex, Inc.
April 24, 2020 Page 2
FirstName LastNameBryan Rowland
Vertex, Inc.
April 24, 2020
Page 2
2.Please clarify your explanation of the usefulness of free cash flow and free cash flow
margin as liquidity measures or performance measures. In this regard, you indicate that
the measures provide useful information in understanding and evaluating your operating
results, while your explanation on page 52 indicates that free cash flow is used in
evaluating period-to-period comparisons of liquidity.
Capitalization, page 42
3.We note you refer to “this offering and the use of proceeds” in the introductory paragraph
to describe the items reflected in your Capitalization table; however, in order to provide an
investor with a clear understanding of the items you have included on a pro forma as
adjusted basis, please include a qualitative and quantitative description for each of the
specific item(s) for which you are giving effect. In addition, following the table, you
indicate that the information presented above includes certain assumptions. Please clarify
which information in the table gives effect to those assumptions.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Overview, page 49
4.You disclose that you had over 4,000 customers and average annual recurring revenue per
customer was over $65,000 as of December 31, 2019. Please revise to disclose such
information for each period presented wherever is applicable throughout the filing.
5.We note that you derive the majority of your revenue from software subscriptions and you
maintain an allowance for subscription cancellations. Please expand your disclosures to
describe the cancellation provisions in your contracts. To the extent that the cancellations
were significant, please disclose how they have impacted your results and earnings trends.
6.We note you are dependent on relationships with third-party publishers of software
business applications. Please tell us what consideration you have given to filing any such
material licenses, or related agreements, as exhibits to your registration statement.
7.You disclose on page 27 that the COVID-19 outbreak has negatively impacted the global
economy and may lead to declines in your customers' revenue, spending and transactions,
which may adversely affect your revenue. Please discuss the reasonably known effects of
the COVID-19 pandemic on your business, financial condition and operating results. We
refer you to Item 303 of Regulation S-K. If material, discuss how the pandemic has
impacted, or may impact, your growth strategy described here and on page 5. For
example, disclose whether you have experienced reduced client spend, collection issues,
or the loss of clients since the COVID-19 outbreak began. In this regard, we note that you
principally price your solutions based on a customer's revenue base, and retention and
expansion of revenue from existing customers is a key factor affecting your performance.
For additional guidance, refer to the Division of Corporation Finance Disclosure Guidance
Topic No. 9 issued March 25, 2020.
FirstName LastNameBryan Rowland
Comapany NameVertex, Inc.
April 24, 2020 Page 3
FirstName LastNameBryan Rowland
Vertex, Inc.
April 24, 2020
Page 3
Components of Our Results of Operations, page 53
8.Please revise to disclose the reasonably likely material future effects of the change in
accounting policy for your stock appreciation rights after becoming a public business
entity. Refer to Question 4 of SAB Topic 14.B.
Internal Control Over Financial Reporting, page 64
9.Please clarify how the errors resulting from the material weaknesses relating to revenue
recognition and capitalized software development costs were addressed in your financial
statements.
Business, page 72
10.You discuss in MD&A that your customers are shifting to your cloud solutions and that
you expect this trend to continue. Please consider discussing your technology
infrastructure for your cloud solutions in the Business section.
Management, page 86
11.Please revise your executives' biographies to clearly identify the time periods associated
with their business experience over the past five years. Refer to Item 401(e) of Regulation
S-K for guidance.
Consolidated Statements of Cash Flows, page F-6
12.Please revise to include column headers for each period.
Notes to Audited Consolidated Financial Statements
Note 1. Summary of significant accounting policies
Earnings Per Share, page F-18
13.Please accurately report the amount of net loss attributable to Class B stockholders for
2018 in your illustration of the calculation of diluted net loss per common share.
Unaudited Pro Forma Earnings Per Share, page F-19
14.We note that pro forma basic and diluted income per share will give effect to the number
of shares of common stock to be issued in the initial public offering described in the
registration statement. It is only appropriate to give effect to the number of shares whose
proceeds will be used to pay dividends or fund distributions to shareholders in excess of
earnings in pro forma per share data. Refer to SAB Topic 1.B.3. Please revise.
FirstName LastNameBryan Rowland
Comapany NameVertex, Inc.
April 24, 2020 Page 4
FirstName LastName
Bryan Rowland
Vertex, Inc.
April 24, 2020
Page 4
Recently Issued Accounting Pronouncements, page F-20
15.We note that you intend to adopt ASU 2017-04 prospectively effective in 2020 with
regard to future business combinations. Please confirm that you will apply this guidance
consistently for goodwill impairment tests performed after adoption. Revise your
disclosure accordingly.
Note 3. Capitalized software, page F-24
16.Based on your disclosures, it appears that you do not begin to amortize capitalized
software until it is placed in service; however, amortization should begin when the
product is available for general release to customers. Refer to ASC 985-20-35-3.
Similarly, we note from your disclosure on page F-23 that internal-use software is not
depreciated until it is placed in service; however, amortization of internal-use software
should begin when the software is ready for its intended use. Refer to ASC 350-40-35-6.
Please revise accordingly.
Note 7. Employee benefit and deferred compensation plans
SAR Plan, page F-29
17.Please expand the note to provide the applicable disclosures related to your stock
appreciation rights arrangements as required by ASC 718-10-50-2(c)(2) and (d).
General
18.Please supplementally provide us with copies of all written communications, as defined in
Rule 405 under the Securities Act, that you, or anyone authorized to do so on your behalf,
present to potential investors in reliance on Section 5(d) of the Securities Act, whether or
not they retain copies of the communications.
You may contact Becky Chow, Staff Accountant, at (202) 551-6524 or Melissa Walsh,
Staff Accountant, at (202) 551-3224 if you have questions regarding comments on the financial
statements and related matters. Please contact Michael C. Foland, Attorney-Advisor, at (202)
551-6711 or Kathleen Krebs, Special Counsel, at (202) 551-3350 with any other questions.
Sincerely,
Division of Corporation Finance
Office of Technology
cc: Joel Trotter